Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07564817 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effects of the Speed Sleep Supplement on Sleep Quality and Quantity
A NA study, sponsored by Bio Nature Health.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT07564817: Completed NA study, sponsored by Bio Nature Health.
NCT07564817 is a NA study that has completed, run by Bio Nature Health. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07564817, a NA study, has completed, sponsored by Bio Nature Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study evaluates the effects of the Speed Sleep supplement on sleep quality and quantity in adults aged 18-65 years. Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed using Fitbit sleep tracking data and questionnaires.
Primary Outcome
Assessed using Fitbit-generated sleep score reflecting overall sleep quality. Higher scores indicate better sleep quality.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Dietary Supplement: Speed Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-11-03 |
| Est. Completion | 2025-01-13 |
| Phase | NA |
What the finished NCT07564817 record still lists
NCT07564817 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07564817 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07564817 about?
NCT07564817 is a clinical study titled "A Study to Evaluate the Effects of the Speed Sleep Supplement on Sleep Quality and Quantity". This study evaluates the effects of the Speed Sleep supplement on sleep quality and quantity in adults aged 18-65 years. Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed using Fitbit sleep tracking data and questionnaires.
What is the current status of trial NCT07564817?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-11-03. Estimated completion is 2025-01-13.
What interventions are being tested in trial NCT07564817?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Dietary Supplement: Speed Sleep (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07564817?
This trial is sponsored by Bio Nature Health, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07564817's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI